Next Article in Journal
IBD Patients with Primary or Secondary Nonresponse to Ustekinumab Benefit from Dose Escalation or Reinduction
Previous Article in Journal
The Effect of Revascularization on Lower Limb Circulation Parameters in Symptomatic Peripheral Arterial Disease
Previous Article in Special Issue
Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study
 
 
Article

Article Versions Notes

J. Clin. Med. 2024, 13(14), 3992; https://doi.org/10.3390/jcm13143992 (registering DOI)
Action Date Notes Link
article xml file uploaded 9 July 2024 06:17 CEST Original file -
article xml uploaded. 9 July 2024 06:17 CEST Update -
article pdf uploaded. 9 July 2024 06:17 CEST Version of Record -
article html file updated 9 July 2024 06:19 CEST Original file -
article xml file uploaded 9 July 2024 08:45 CEST Update -
article xml uploaded. 9 July 2024 08:45 CEST Update https://www.mdpi.com/2077-0383/13/14/3992/xml
article pdf uploaded. 9 July 2024 08:45 CEST Updated version of record https://www.mdpi.com/2077-0383/13/14/3992/pdf
article html file updated 9 July 2024 08:47 CEST Update https://www.mdpi.com/2077-0383/13/14/3992/html
Back to TopTop